Multipotent mesenchymal stem cells (MSCs) are a heterogeneous population of cells which reside in a variety of tissues. They differentiate into several mesodermal lineages, secrete a multitude of trophic factors and contribute to tissue homeostasis. MSCs are able to exert immunosuppressive activities by interfering with inflammatory cytokine production and with T- and B-cell proliferation. These immunomodulating properties make MSCs promising candidates for the treatment of chronic inflammatory and autoimmune disorders. There are, however, certain caveats involved including inappropriate migration of cells in the body, immune rejection, tumor formation, or graft versus host disease (GvHD).
This book investigates the current state of the MSC-dependent therapy of chronic inflammatory disorders and autoimmune diseases. Among the covered topics are GvHD, chronic kidney, liver and lung disease, ischemic heart and inflammatory bowel disease, diabetes, osteoarthritis, various rheumatic and neurological disorders and, lastly, tumors and solid organ transplantations. This book also questions the immunoprivileged status of MSCs, discusses the therapeutic role of MSCs in experimental animal disease models and their translation to the corresponding human disorders, envisions a role for MSCs in tumor interventions and, lastly, describes a systems biology approach for stem cells and inflammation.

Frequently asked questions

Simply head over to the account section in settings and click on “Cancel Subscription” - it’s as simple as that. After you cancel, your membership will stay active for the remainder of the time you’ve paid for. Learn more here.

At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.

Both plans give you full access to the library and all of Perlego’s features. The only differences are the price and subscription period: With the annual plan you’ll save around 30% compared to 12 months on the monthly plan.

We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.

Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.

Yes, you can access Stem Cell-Dependent Therapies by Gerhard Gross, Thomas Häupl, Gerhard Gross, Thomas Häupl in PDF and/or ePUB format, as well as other popular books in Medicine & Biotechnology in Medicine. We have over one million books available in our catalogue for you to explore.

Information

Publisher

De Gruyter

Year

2013

ISBN

9783110298307

Edition

Topic

Medicine

Subtopic

Biotechnology in Medicine

Preface
Contributing authors
1 Mesenchymal stem cells in the context of stem cell biology
2 Are mesenchymal stem cells immune privileged?
3 Mesenchymal stem cell therapies for autoimmune diseases
4 Mesenchymal stem cells in osteoarthritis and rheumatic disease
5 Mesenchymal stem cells in enthesis formation and repair
6 Mesenchymal stem cells for clinical/therapeutic interventions of graft-versus-host disease
7 Mesenchymal stem cells for graft-versus-host disease in experimental animal models
8 Mesenchymal stem cells and organ transplantation: initial clinical results
9 Stem cell therapy in patients with ischemic heart disease
10 Mesenchymal stem cells as a strategy for the treatment of multiple sclerosis and other diseases of the central nervous system
11 Mesenchymal stem cells for the treatment of inflammatory bowel disease
12 Mesenchymal stem cells in chronic lung diseases: COPD and lung fibrosis
13 Mesenchymal stem cells as therapeutics for liver repair and regeneration
14 Mesenchymal stem cells attenuate renal fibrosis
15 Immunomodulation by mesenchymal stem cells – a potential therapeutic strategy for type 1 diabetes
16 Fibrogenic potential of human multipotent mesenchymal stem cells in inflammatory environments
17 Mesenchymal stem cells and the tumor microenvironment
18 Mesenchymal stem cells as a carrier for tumor-targeting therapeutics
19 Systems biology approach to stem cells, tissues and inflammation
Index